A detailed history of Jane Street Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Jane Street Group, LLC holds 2,319,864 shares of BMY stock, worth $134 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,319,864
Previous 4,113,834 43.61%
Holding current value
$134 Million
Previous $171 Million 29.73%
% of portfolio
0.03%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$39.66 - $51.75 $71.1 Million - $92.8 Million
-1,793,970 Reduced 43.61%
2,319,864 $120 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $109 Million - $143 Million
2,706,696 Added 192.35%
4,113,834 $171 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $151 Million - $171 Million
-3,147,431 Reduced 69.1%
1,407,138 $76.3 Million
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $46.7 Million - $55.7 Million
962,744 Added 26.8%
4,554,569 $234 Million
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $182 Million - $204 Million
3,144,431 Added 702.83%
3,591,825 $208 Million
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $19.4 Million - $21.6 Million
305,108 Added 214.43%
447,394 $28.6 Million
Q1 2023

May 15, 2023

SELL
$65.71 - $74.53 $26.8 Million - $30.4 Million
-408,463 Reduced 74.17%
142,286 $9.86 Million
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $24.5 Million - $29 Million
357,427 Added 184.89%
550,749 $39.6 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $121,500 - $71.8 Million
-934,622 Reduced 82.86%
193,322 $13.7 Million
Q2 2022

Aug 16, 2022

SELL
$72.62 - $79.98 $26.6 Million - $29.3 Million
-366,786 Reduced 24.54%
1,127,944 $86.9 Million
Q1 2022

May 17, 2022

BUY
$61.48 - $73.72 $60.1 Million - $72.1 Million
977,710 Added 189.1%
1,494,730 $109 Million
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $22.7 Million - $26.4 Million
422,631 Added 447.75%
517,020 $32.2 Million
Q3 2021

Nov 16, 2021

SELL
$59.17 - $69.31 $41.8 Million - $49 Million
-707,080 Reduced 88.22%
94,389 $5.59 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $14 Million - $15.2 Million
225,592 Added 39.17%
801,469 $53.6 Million
Q1 2021

May 18, 2021

BUY
$59.34 - $66.74 $21 Million - $23.6 Million
354,101 Added 159.67%
575,877 $36.4 Million
Q4 2020

Feb 17, 2021

SELL
$57.74 - $65.43 $18.3 Million - $20.8 Million
-317,159 Reduced 58.85%
221,776 $13.8 Million
Q3 2020

Nov 17, 2020

SELL
$57.43 - $63.64 $21.1 Million - $23.4 Million
-367,816 Reduced 40.56%
538,935 $32.5 Million
Q2 2020

Aug 17, 2020

BUY
$54.82 - $64.09 $30.3 Million - $35.4 Million
551,879 Added 155.51%
906,751 $53.3 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $18.3 Million - $26.7 Million
-395,434 Reduced 52.7%
354,872 $19.8 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $30.4 Million - $39.6 Million
617,646 Added 465.59%
750,306 $48.2 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $1.27 Million - $1.5 Million
29,623 Added 28.75%
132,660 $6.73 Million
Q2 2019

Aug 15, 2019

SELL
$44.62 - $49.34 $22.9 Million - $25.4 Million
-514,034 Reduced 83.3%
103,037 $4.67 Million
Q1 2019

May 16, 2019

BUY
$45.12 - $53.8 $26.1 Million - $31.2 Million
579,045 Added 1522.76%
617,071 $29.4 Million
Q4 2018

Feb 15, 2019

SELL
$48.76 - $63.23 $4.14 Million - $5.37 Million
-84,875 Reduced 69.06%
38,026 $1.98 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $450,019 - $507,586
8,154 Added 7.11%
122,901 $7.63 Million
Q2 2018

Aug 15, 2018

BUY
$50.53 - $62.98 $1.19 Million - $1.48 Million
23,560 Added 25.84%
114,747 $6.35 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $2.9 Million - $3.34 Million
48,458 Added 113.41%
91,187 $5.77 Million
Q4 2017

Feb 15, 2018

SELL
$59.94 - $65.35 $7.26 Million - $7.91 Million
-121,055 Reduced 73.91%
42,729 $2.62 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $9.05 Million - $10.4 Million
163,784
163,784 $10.4 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.